Preoperative systemic inflammation response index: Clinicopathologic predictor of pathological complete response in HER2-positive breast cancer patients receiving neoadjuvant systemic therapy.

J Chin Med Assoc · 2024 · PMC12718766 · PMID 38095571

Europe PMC DOI

hedged sentence

0.0620

closest p · 1.2× alpha

0.0620

boldest claim

The sentences

did not reach statistical significancep = 0.062so close (0.05 < p ≤ 0.1)

In trastuzumab + pertuzumab subgroup, while HER2 IHC 3+ (OR = 8.99), ER+/PR+ (OR = 0.20), and SIRI ≥1.27 (OR = 0.23) were correlated with pCR, cN stage did not reach statistical significance ( p = 0.062).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.